| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ATRICURE INC | 548,611 | 13,518,000 | 11.43% | SH | |
| 2 | ABBVIE INC | 116,581 | 7,833,000 | 6.62% | ||
| 3 | NXSTAGE MED INC COM | 366,554 | 5,236,000 | 4.43% | SH | |
| 4 | ACHILLION PHARMACEUTICALS INC COM | 480,300 | 4,255,000 | 3.60% | SH | |
| 5 | RIGEL PHARMACEUTICAL INC | 1,109,740 | 3,562,000 | 3.01% | SH | |
| 6 | ZS PHARMA INC | 67,100 | 3,515,000 | 2.97% | ||
| 7 | BIOCRYST PHARMACEUTICALS | 221,656 | 3,309,000 | 2.80% | SH | |
| 8 | INSULET CORPORATION | 106,018 | 3,285,000 | 2.78% | SH | |
| 9 | DISCOVERY LABORATORIES INC N | 4,794,874 | 3,261,000 | 2.76% | SH | |
| 10 | XENOPORT INC | 531,032 | 3,255,000 | 2.75% | SH | |
| 11 | PROTALIX BIOTHERAPEUTICS INC | 4,000,000 | 3,196,000 | 2.70% | PRN | |
| 12 | AERIE PHARMACEUTICALS INC | 156,842 | 2,768,000 | 2.34% | SH | |
| 13 | DERMA SCIENCES INC COM PAR .01 | 373,918 | 2,677,000 | 2.26% | SH | |
| 14 | SYNERGY PHARMACEUTICALS DEL COM NEW | 317,563 | 2,636,000 | 2.23% | ||
| 15 | ESSA Pharma | 231,200 | 2,626,000 | 2.22% | ||
| 16 | Otonomy Inc | 111,466 | 2,563,000 | 2.17% | ||
| 17 | APPLIED GENETIC TECHNOL CORP | 157,192 | 2,411,000 | 2.04% | ||
| 18 | PROTALIX BIOTHERAPEUTICS INC | 1,230,789 | 2,400,000 | 2.03% | SH | |
| 19 | INSULET CORP 2 06/15/2019 | 2,407,000 | 2,338,000 | 1.98% | PRN | |
| 20 | BIOTELEMETRY INC COM | 235,645 | 2,222,000 | 1.88% | SH | |
| 21 | CLOVIS ONCOLOGY INC | 23,090 | 2,029,000 | 1.72% | SH | |
| 22 | Stereotaxis Inc | 1,372,862 | 1,977,000 | 1.67% | SH | |
| 23 | MASIMO CORP COM | 46,010 | 1,782,000 | 1.51% | SH | |
| 24 | CYNAPSUS THERAPEUTICS INC | 94,824 | 1,730,000 | 1.46% | ||
| 25 | Neothetics Inc | 184,187 | 1,658,000 | 1.40% | SH | |
| 26 | Ascendis Pharma | 93,541 | 1,654,000 | 1.40% | ||
| 27 | CELYAD SA | 30,000 | 1,561,000 | 1.32% | ||
| 28 | CARA THERAPEUTICS INC | 126,956 | 1,543,000 | 1.31% | ||
| 29 | ZOGENIX INC | 853,700 | 1,434,000 | 1.21% | ||
| 30 | SCYNEXIS INC | 161,382 | 1,419,000 | 1.20% | SH | |
| 31 | TARGACEPT INC | 463,914 | 1,294,000 | 1.09% | SH | |
| 32 | NOVADAQ TECHNOLOGIES INC | 101,841 | 1,233,000 | 1.04% | SH | |
| 33 | Dicerna Pharmaceuticals | 86,800 | 1,211,000 | 1.02% | ||
| 34 | CYTRX CORP | 300,813 | 1,119,000 | 0.95% | SH | |
| 35 | UNIQURE NV | 40,000 | 1,080,000 | 0.91% | SH | |
| 36 | BLUEBIRD BIO INCORPORATED | 6,000 | 1,010,000 | 0.85% | SH | |
| 37 | DERMIRA INC | 56,736 | 996,000 | 0.84% | ||
| 38 | NUVASIVE INC | 760,000 | 968,000 | 0.82% | PRN | |
| 39 | SYNERON MEDICAL LTD ORD SHS | 90,947 | 966,000 | 0.82% | SH | |
| 40 | CAREDX INC | 145,627 | 947,000 | 0.80% | SH | |
| 41 | JOHNSON & JOHNSON | 9,400 | 916,000 | 0.77% | SH | |
| 42 | SPECTRANETICS CORP | 39,812 | 916,000 | 0.77% | SH | |
| 43 | ARENA PHARMACEUTICALS INC | 189,000 | 877,000 | 0.74% | ||
| 44 | CARDICA INC | 1,486,004 | 742,000 | 0.63% | SH | |
| 45 | LIPOCINE INC NEW | 85,000 | 729,000 | 0.62% | ||
| 46 | Exactech Inc | 31,636 | 659,000 | 0.56% | SH | |
| 47 | ARCA BIOPHARMA INC COM NEW | 567,859 | 653,000 | 0.55% | ||
| 48 | ENCISION INC | 1,062,500 | 584,000 | 0.49% | SH | |
| 49 | Cogentix Medical Inc | 353,181 | 572,000 | 0.48% | ||
| 50 | CYNAPSUS THERAPEUTICS INC | 33,995 | 559,000 | 0.47% | SH |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-15-000016, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
